top of page

Investments

We bring our innovative touch to every project, proving that nothing is impossible.

We share our business building experience to grow step by step.
LynxCare decentralized trials leading the healthcare data revolution Lynx logo round

01

LynxCare

Company Creation : September 2015

Series A: June 2022

ballas invest-ment : December 2023

Decentralised trials

Real World Evidence

  • Data structuring

  • Patient recruitment & selection

  • Data gathering

Monka aider est notre métier logo

02

Monka

Company Creation : July 2021

Seed Business Angel : March 2023

ballas invest-ment: March 2023

AI enabled solution for helpers and elderly people.

  • Personalised care ecosystem

  • Dedicated nurses 

  • Digital tools

Whitelab Genomics AI solutions for accelerated Genomic medecine logo black only the symbol

03

WhiteLab Genomics

Company Creation : March 2019

Series A : September 2022

ballas invest-ment : September 2023

AI for Genomic Medicine

  • Specialised ai platform for DNA and RNA therapies

  • Accelerate discovery and developments with machine learning

Elixir health reproductive health boosted by AI purple logo round

04

Elixir Health

Company Creation : May 2022

Seed Business Angel : August 2023

ballas invest-ment : August 2023

Reproductive Health boosted by AI

Improve assisted reproductive care pathway for patients & healthcare professionals

  • AI powered clinical decision support

  • Software interface

ECLEVAR MEDTECH logo qui est une CRO unique en son genre, qui réunit l'expertise de l'autorité compétente, de l'organisme notifié, de l'industrie et de la CRO

05

Eclevar

Company Creation : September 2020
Seed Business Angel : February 2024

ballas invest-ment : February 2024

MedTech CRO powered by unique software and HCP network

Operating in a dozen medical areas from cardiology, dental, dermatology to orthopaedics
Milo software gives unique patients access to their HCP allowing them to connect and receive high quality medical care 24/7

Heloa aux côtés des familles logo orange

06

Heloa

Company Creation : February 2020
Seed Business Angel : March 2024

ballas invest-ment : March 2024

Patient Care - Applied Prevention

  • 120,000 connected parents

  • Personalised health monitoring

  • Helps you to take care of yourself and your children, from birth to day to day family care

  • Post partum depression and neurological development

The future of neuroimaging analysis is here and Qynapse is leading the way. For clinicians on the front lines, for patients and their families, for payers, and for pharma – we offer peace of mind by providing results you can trust. Logo

07

Qynapse

Company Creation : 2015
Seed Business Angel : June 2024

ballas invest-ment : May 2024

Qyscore - AI-powered and proprietary neuroimaging software platform

Combining MRI scans and artificial intelligence to produce rapid, actionable insights into central nervous system (CNS) disorders.

Hexoskin Health sensors and AI logo

08

Hexoskin

Company Creation : 2006
Seed Business Angel : June 2024

ballas invest-ment : June 2024

Non-invasive sensors, software, data science & AI services

Provides solutions and services directly to customers, developers, and researchers & professionals in : pharmaceuticals, academics, healthcare, defense, first responders, space, and aerospace organizations.

Wandercraft an ordinary life for extraordinary people logo

09

Wandercraft

Company Creation : 2012
Seed Business Angel : January 2022

ballas invest-ment : July 2024

Atalante X - Hands-free walk exoskeleton

Atalante X is designed to minimize training time for both patient and therapist. This easy-to-use exoskeleton helps you optimize your sessions, by increasing treatment productivity and step dosage.

Quantum Biospace by BVI.eu LOGO

10

Quantum BioSpace

Company Creation : March 2023
Seed Business Angel : November 2024

ballas invest-ment : November 2024

TechBio Science park

Offering Life Sciences and Technology companies the ideal ecosystem to transform drug discovery, development and manufacturing using data-driven approaches.

bottom of page